| Highly multiplexed proteomic assessment of human bone marrow in acute myeloid leukemia H Çelik, KE Lindblad, B Popescu, G Gui, M Goswami, J Valdez, ... Blood Advances 4 (2), 367-379, 2020 | 36 | 2020 |
| Timed sequential salvage chemotherapy for relapsed or refractory acute myeloid leukemia B Popescu, S Sheela, J Thompson, S Grasmeder, T Intrater, ... Clinical hematology international 2 (1), 27-31, 2020 | 6 | 2020 |
| NGS combined with phylogenetic analysis to detect HIV-1 dual infection in Romanian people who inject drugs B Popescu, L Banica, I Nicolae, E Radu, I Niculescu, A Abagiu, D Otelea, ... Microbes and Infection 20 (5), 308-311, 2018 | 6 | 2018 |
| Sidestepping SHP2 inhibition B Popescu, K Shannon The Journal of Experimental Medicine 220 (5), 2023 | 3 | 2023 |
| Venetoclax and dinaciclib elicit synergistic preclinical efficacy against hypodiploid acute lymphoblastic leukemia H Pariury, J Fandel, S Bachl, KK Ang, S Markossian, CG Wilson, ... Haematologica 108 (5), 1272, 2023 | 3 | 2023 |
| Downregulation of hsa-miR-4328 and target gene prediction in Acute Promyelocytic Leukemia OT Lupu, B Popescu, E Avram, M Dragomir, GD Cimponeriu, I Mighiu, ... Revista Romana de Medicina de Laborator 30 (3), 261-272, 2022 | 2 | 2022 |
| Allosteric SHP2 Inhibitor RMC4550 Synergizes with Venetoclax in FLT3 and KIT Mutant Acute Myeloid Leukemia B Popescu, C Stahlhut, TC Tarver III, TT Ferng, C Peretz, S Wishner, ... Blood 138, 2231, 2021 | 2 | 2021 |
| RAS MULTI (ON) inhibitor RMC-7977 targets oncogenic RAS mutations and overcomes RAS/MAPK-mediated resistance to FLT3 inhibitors in AML models B Popescu, E Stieglitz, CC Smith Blood 142, 2793, 2023 | 1 | 2023 |
| Allosteric SHP2 inhibition increases apoptotic dependency on BCL2 and synergizes with venetoclax in FLT3-and KIT-mutant AML B Popescu, C Stahlhut, TC Tarver, S Wishner, BJ Lee, CAC Peretz, ... Cell Reports Medicine 4 (11), 2023 | 1 | 2023 |
| Allosteric SHP2 Inhibition Increases Apoptotic Dependency on BCL2 and Synergizes with Venetoclax inFLT3-andKIT-Mutant AML B Popescu, C Stahlhut, TC Tarver, S Wishner, BJ Lee, CAC Peretz, ... | 1 | 2022 |
| A Novel Proteomic Profiling of the Bone Marrow Microenvironment Reveals Elevated Levels of the Chemokine CCL23 Isoforms in Acute Myeloid Leukemia H Celik, KE Lindblad, B Popescu, G Fantoni, G Gui, J Valdez, M Goswami, ... Blood 134, 2709, 2019 | 1 | 2019 |
| Coexpression of p190 and p210 Fusion Transcripts in Ph+ Acute Lymphoblastic Leukemia. A Case Report MC Stancuioaica, B Popescu, C Popa, C Jardan, M Dragomir, D Coriu Clinical Lymphoma, Myeloma and Leukemia 19, S194-S195, 2019 | 1 | 2019 |
| DNA Sequencing of CD138 Cell Population Reveals TP53 and RAS-MAPK Mutations in Multiple Myeloma at Diagnosis M Dragomir, OT Călugăru, B Popescu, C Jardan, D Jardan, M Popescu, ... Cancers 16 (2), 358, 2024 | | 2024 |
| Threshold Attenuation of Perk Signaling Is Sufficient to Overcome RAS-Mediated FLT3 Inhibitor Resistance CAC Peretz, E Tran, B Popescu, VE Kennedy, T Kumar, L McGary, ... Blood 142, 4171, 2023 | | 2023 |
| AML-258: Next-Generation Sequencing Used to Detect Multiple Mutations in Acute Myeloid Leukemia Patients A Vulpe, M Dragomir, D Jardan, S Aposteanu, C Jardan, A Tatic, ... Clinical Lymphoma Myeloma and Leukemia 20, S196, 2020 | | 2020 |
| Immunological features of immune-related adverse events during anti-PD-1/PD-L1 immune checkpoint inhibition M Goswami, G Gui, K Lindblad, J Del Rivero, J Marte, P Dagur, ... JOURNAL FOR IMMUNOTHERAPY OF CANCER 7, 2019 | | 2019 |
| The Management of Secondary Resistance CP-CML–Case Report M Dragomir, S Aposteanu, A Trifu, A Vulpe, R Talmaci, B Popescu, ... Clinical Lymphoma, Myeloma and Leukemia 19, S297-S298, 2019 | | 2019 |
| Highly multiplexed proteomic assessment of the human acute myeloid leukemia bone marrow microenvironment B Popescu, K Lindblad, G Fantoni, G Gui, J Valdez, M Goswami, ... Cancer Research 79 (13_Supplement), 3756-3756, 2019 | | 2019 |
| Double Trouble: HIV-1 and HTLV-1 Coinfection in Romanian ATL Patients. A Case Series B Popescu, A Bardas, C Dobrea, MC Stancioaica, D Coriu Clinical Lymphoma, Myeloma and Leukemia 18, S287, 2018 | | 2018 |
